Moghimi, Minoo
Clinical Pharmacy Resident, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
[ 1 ] - Efficacy of Tocilizumab in Patients with COVID-19
Background and purpose: Tocilizumab (TCZ), a monoclonal antibody against interleukin-6 (IL-6) receptor, is emerged as an alternative treatment for COVID-19 patients with a risk of cytokine storms. This study aimed at investigating the efficacy of TCZ in patients with COVID-19. Materials and methods: In a retrospective observational study, we examined the demographic and clinical characteristi...